Structural Modification of c-abl in Lymphoma and Leukemia
Vertebrate DNA contains a gene, named c-abl, that was disclosed by a rapidly oncogenic retrovirus, Abelson murine leukemia virus (A-MuLV)- A-MuLV carries a portion of c-abl (Goff et al., 1980) including a region encoding a protein-tyrosine kinase which is essential to the oncogenic activity of A-MuLV (Prywes et al., 1983). The cellular protein product of c-abl, like that of v-abl, is an active protein kinase (Konopka et al., 1985; Ben-Neriah et al., 1986a).
KeywordsChronic Myelogenous Leukemia Chronic Myelogenous Leukemia Cell Viral Construct mRNA Type Chronic Myelogenous Leukemia Case
Unable to display preview. Download preview PDF.
- Bartram CR (1985) bcr rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia. J Exp Med 162:2175–2179.Google Scholar
- Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON and Baltimore D (1986a, to be published) The chronic myelogenous leukemia specific P210 protein is the product of the bcr/abl hybrid gene. Science.Google Scholar
- Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR and Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region bcr on chromosome 22. Cell 36: 93–99.Google Scholar
- Grosveld G, Verwoerd T, Van-Agthoven T, de Klein A, Ramachandran KL, Heisterkamp N, Stam K and Groffen J (1986) The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol 6: 607–616.Google Scholar
- Heisterkamp N, Stam K, Groffen J, de Klein A and Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 315: 758–761.Google Scholar
- Sefton BM, Trowbridge IS, Cooper JA and Scolnick EM (1982) The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell 31: 465–474.Google Scholar